Citations (133)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Adel Mandl, Mark C. Markowski, Michael A. Carducci & Emmanuel S. Antonarakis. (2023) Role of bromodomain and extraterminal (BET) proteins in prostate cancer. Expert Opinion on Investigational Drugs 32:3, pages 213-228.
Read now
Read now
Rebecca R. Fisher, Haley M. Pleskow, Kathleen Bedingfield & David T. Miyamoto. (2020) Noncanonical Wnt as a prognostic marker in prostate cancer: “you can’t always get what you Wnt”. Expert Review of Molecular Diagnostics 20:2, pages 245-254.
Read now
Read now
Mark C. Markowski, Angelo M. De Marzo & Emmanuel S. Antonarakis. (2017) BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations. Expert Opinion on Investigational Drugs 26:12, pages 1391-1397.
Read now
Read now
Bodo Melnik. (2011) Isotretinoin and FoxO1. Dermato-Endocrinology 3:3, pages 141-165.
Read now
Read now
Masahiro OGAWA, Ryoichi YAMAJI, Takakazu MITANI, Yohei MURATA, Motoyuki NAKAO, Naoki HARADA, Yoshihisa NAKANO & Hiroshi INUI. (2010) A Yeast Bioassay for Androgenic and Anti-Androgenic Compounds Based on the NH2- and COOH-Terminal Interaction of Androgen Receptor. Bioscience, Biotechnology, and Biochemistry 74:9, pages 1965-1968.
Read now
Read now
Alexander Schepsky, Katja Bruser, Gunnar J. Gunnarsson, Jane Goodall, Jón H. Hallsson, Colin R. Goding, Eirikur Steingrimsson & Andreas Hecht. (2006) The Microphthalmia-Associated Transcription Factor Mitf Interacts with β-Catenin To Determine Target Gene Expression. Molecular and Cellular Biology 26:23, pages 8914-8927.
Read now
Read now
Shao-Yong Chen, Gerburg Wulf, Xiao Zhen Zhou, Mark A. Rubin, Kun Ping Lu & Steven P. Balk. (2006) Activation of β-Catenin Signaling in Prostate Cancer by Peptidyl-Prolyl Isomerase Pin1-Mediated Abrogation of the Androgen Receptor-β-Catenin Interaction. Molecular and Cellular Biology 26:3, pages 929-939.
Read now
Read now
Articles from other publishers (126)
Corrigan Horton, Yueli Liu, Jiawen Wang, Jonathan Green, Jeremiah Tsyporin, Bin Chen & Zhu A. Wang. (2023) Modulation of the canonical Wnt activity by androgen signaling in prostate epithelial basal stem cells. Stem Cell Reports.
Crossref
Crossref
Nishat Manzar, Promit Ganguly, Umar Khalid Khan & Bushra Ateeq. (2023) Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer. Seminars in Cancer Biology 89, pages 76-91.
Crossref
Crossref
Meera Patel, Kathryn A. F. Pennel, Jean A. Quinn, Hannah Hood, David K. Chang, Andrew V. Biankin, Selma Rebus, Antonia K. Roseweir, James H. Park, Paul G. Horgan, Donald C. McMillan & Joanne Edwards. (2022) Spatial expression of IKK-alpha is associated with a differential mutational landscape and survival in primary colorectal cancer. British Journal of Cancer 126:12, pages 1704-1714.
Crossref
Crossref
Katie Joanna Miller & Mohammad Asim. (2022) Unravelling the Role of Kinases That Underpin Androgen Signalling in Prostate Cancer. Cells 11:6, pages 952.
Crossref
Crossref
Margherita Corti, Stefano Lorenzetti, Alessandro Ubaldi, Romano Zilli & Daniele Marcoccia. (2022) Endocrine Disruptors and Prostate Cancer. International Journal of Molecular Sciences 23:3, pages 1216.
Crossref
Crossref
Gabrielle Ferrante Alves de Moraes, Eduardo Listik, Giselle Zenker Justo, Carolina Meloni Vicente & Leny Toma. (2021) The Glypican proteoglycans show intrinsic interactions with Wnt-3a in human prostate cancer cells that are not always associated with cascade activation. BMC Molecular and Cell Biology 22:1.
Crossref
Crossref
Thomas Steele, Anhao Sam, Shawna Evans, Elizabeth Browning, Sheryl Krig, Katelyn Macias, Adarsh Konda, Salma Siddiqui, Blythe Durbin-Johnson, Paramita Ghosh & Ruth Vinall. (2021) Androgen Receptor-Mediated Nuclear Transport of NRDP1 in Prostate Cancer Cells Is Associated with Worse Patient Outcomes. Cancers 13:17, pages 4425.
Crossref
Crossref
Heidi Fettke, Edmond M. Kwan, Patricia Bukczynska, Jason A. Steen, Maria Docanto, Nicole Ng, Phillip Parente, Andrew Mant, Siavash Foroughi, Carmel Pezaro, Christine Hauser, Tu Nguyen‐Dumont, Melissa C. Southey & Arun A. Azad. (2021) Independent prognostic impact of plasma NCOA2 alterations in metastatic castration‐resistant prostate cancer. The Prostate 81:13, pages 992-1001.
Crossref
Crossref
Ke‐Fan Pan, Wei‐Jiunn Lee, Chun‐Chi Chou, Yi‐Chieh Yang, Yu‐Chan Chang, Ming‐Hsien Chien, Michael Hsiao & Kuo‐Tai Hua. (2020) Direct interaction of β‐catenin with nuclear ESM1 supports stemness of metastatic prostate cancer. The EMBO Journal 40:4.
Crossref
Crossref
Yuran Qiu, Xinyi Li, Xinheng He, Jun Pu, Jian Zhang & Shaoyong Lu. (2020) Computational methods-guided design of modulators targeting protein-protein interactions (PPIs). European Journal of Medicinal Chemistry 207, pages 112764.
Crossref
Crossref
Qi Wang, Jun-Yu Shen, Rui Zhang, Jia-Wei Hong, Zheng Li, Zhen Ding, Heng-Xue Wang, Jin-Peng Zhang, Mei-Rong Zhang & Li-Chun Xu. (2020) Effects and mechanisms of pyrethroids on male reproductive system. Toxicology 438, pages 152460.
Crossref
Crossref
Alexandra Kollara, Premalatha Shathasivam, Soyeon Park, Maurice J. Ringuette & Theodore J. Brown. (2020) Increased androgen receptor levels and signaling in ovarian cancer cells by VEPH1 associated with suppression of SMAD3 and AKT activation. The Journal of Steroid Biochemistry and Molecular Biology 196, pages 105498.
Crossref
Crossref
Sahyun Pak, Sejun Park, Yunlim Kim, Jung-Hyuck Park, Chan-Hee Park, Kyoung-June Lee, Choung-soo Kim & Hanjong Ahn. (2019) The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. Journal of Experimental & Clinical Cancer Research 38:1.
Crossref
Crossref
Namrata Khurana & Suresh C. Sikka. (2019) Interplay Between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences 20:9, pages 2066.
Crossref
Crossref
Masato Takimoto. (2019) Multidisciplinary Roles of LRRFIP1/GCF2 in Human Biological Systems and Diseases. Cells 8:2, pages 108.
Crossref
Crossref
Jeffrey A. Schneider, Timothy W. Craven, Amanda C. Kasper, Chi Yun, Michael Haugbro, Erica M. Briggs, Vladimir Svetlov, Evgeny Nudler, Holger Knaut, Richard Bonneau, Michael J. Garabedian, Kent Kirshenbaum & Susan K. Logan. (2018) Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer. Nature Communications 9:1.
Crossref
Crossref
Jeffrey A. Schneider & Susan K. Logan. (2018) Revisiting the role of Wnt/β-catenin signaling in prostate cancer. Molecular and Cellular Endocrinology 462, pages 3-8.
Crossref
Crossref
Sinjini Sikdar & Susmita Datta. (2017) A novel statistical approach for identification of the master regulator transcription factor. BMC Bioinformatics 18:1.
Crossref
Crossref
Kenneth C. Valkenburg, Angelo M. De Marzo & Bart O. Williams. (2017) Deletion of tumor suppressors adenomatous polyposis coli and Smad4 in murine luminal epithelial cells causes invasive prostate cancer and loss of androgen receptor expression. Oncotarget 8:46, pages 80265-80277.
Crossref
Crossref
Daisuke Nakata, Ryokichi Koyama, Kazuhide Nakayama, Satoshi Kitazawa, Tatsuya Watanabe & Takahito Hara. (2017) Glycogen synthase kinase-3 inhibitors suppress the AR-V7-mediated transcription and selectively inhibit cell growth in AR-V7-positive prostate cancer cells. The Prostate 77:9, pages 955-961.
Crossref
Crossref
Won Ik Seo, Seoyoung Park, Jungsug Gwak, Bong Gun Ju, Jae Il Chung, Pil Moon Kang & Sangtaek Oh. (2017) Wnt signaling promotes androgen-independent prostate cancer cell proliferation through up-regulation of the hippo pathway effector YAP. Biochemical and Biophysical Research Communications 486:4, pages 1034-1039.
Crossref
Crossref
Seham Skah, Joel Uchuya-Castillo, Maria Sirakov & Michelina Plateroti. (2017) The thyroid hormone nuclear receptors and the Wnt/β-catenin pathway: An intriguing liaison. Developmental Biology 422:2, pages 71-82.
Crossref
Crossref
Hubert Pakula, Dongxi Xiang & Zhe Li. (2017) A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland. Cancers 9:12, pages 14.
Crossref
Crossref
Ke Li, Yunhua Mao, Li Lu, Cheng Hu, Dejuan Wang, Jie Si-Tu, Minhua Lu, Shubin Peng, Jianguang Qiu & Xin Gao. (2016) Silencing of CDC20 suppresses metastatic castration-resistant prostate cancer growth and enhances chemosensitivity to docetaxel. International Journal of Oncology 49:4, pages 1679-1685.
Crossref
Crossref
Tyler M. Bauman, Chad M. Vezina, Emily A. Ricke, Richard B. Halberg, Wei Huang, Richard E. Peterson & William A. Ricke. (2016) Expression and colocalization of β-catenin and lymphoid enhancing factor-1 in prostate cancer progression. Human Pathology 51, pages 124-133.
Crossref
Crossref
Annette S. Flozak, Anna P. Lam & Cara J. Gottardi. 2016. Wnt Signaling. Wnt Signaling
49
60
.
Kai Kretzschmar, Denny L. Cottle, Pawel J. Schweiger & Fiona M. Watt. (2015) The Androgen Receptor Antagonizes Wnt/β-Catenin Signaling in Epidermal Stem Cells. Journal of Investigative Dermatology 135:11, pages 2753-2763.
Crossref
Crossref
Fuzheng Guo, Jordan Lang, Jiho Sohn, Elizabeth Hammond, Marcello Chang & David Pleasure. (2015) Canonical Wnt signaling in the oligodendroglial lineage-puzzles remain. Glia 63:10, pages 1671-1693.
Crossref
Crossref
Ji Ho Suh, Arundhati Chattopadhyay, Douglas H. Sieglaff, Cheryl Storer Samaniego, Marc B. Cox & Paul Webb. (2015) Similarities and Distinctions in Actions of Surface-Directed and Classic Androgen Receptor Antagonists. PLOS ONE 10:9, pages e0137103.
Crossref
Crossref
Cheryl Storer Samaniego, Ji Ho Suh, Arundhati Chattopadhyay, Karen Olivares, Naihsuan Guy, Jeffrey C. Sivils, Prasenjit Dey, Fumiaki Yumoto, Robert J. Fletterick, Anders M. Strom, Jan-Åke Gustafsson, Paul Webb & Marc B. Cox. (2015) The FKBP52 Cochaperone Acts in Synergy with β-Catenin to Potentiate Androgen Receptor Signaling. PLOS ONE 10:7, pages e0134015.
Crossref
Crossref
Narender Kumar, Swati Srivastava & Partha Roy. (2015) Impact of low molecular weight phthalates in inducing reproductive malfunctions in male mice: Special emphasis on Sertoli cell functions. General and Comparative Endocrinology 215, pages 36-50.
Crossref
Crossref
Yan Ru (Ellen) Gao, Kirsty A. Walters, Reena Desai, Hong Zhou, David J. Handelsman & Ulla Simanainen. (2014) Androgen Receptor Inactivation Resulted in Acceleration in Pubertal Mammary Gland Growth, Upregulation of ERα Expression, and Wnt/β-Catenin Signaling in Female Mice. Endocrinology 155:12, pages 4951-4963.
Crossref
Crossref
Wen-Hui Lien & Elaine Fuchs. (2014) Wnt some lose some: transcriptional governance of stem cells by Wnt/β-catenin signaling. Genes & Development 28:14, pages 1517-1532.
Crossref
Crossref
Chen U. Zhang & Ken M. Cadigan. 2014. Wnt Signaling in Development and Disease. Wnt Signaling in Development and Disease
51
71
.
F.Z.X. Lean, S. Kontos & C. Palmieri. (2014) Expression of β-catenin and Mesenchymal Markers in Canine Prostatic Hyperplasia and Carcinoma. Journal of Comparative Pathology 150:4, pages 373-381.
Crossref
Crossref
Minyoung Lim, Maya Otto-Duessel, Miaoling He, Leila Su, Dan Nguyen, Emily Chin, Tamara Alliston & Jeremy O. Jones. (2014) Ligand-Independent and Tissue-Selective Androgen Receptor Inhibition by Pyrvinium. ACS Chemical Biology 9:3, pages 692-702.
Crossref
Crossref
G T Lee, D I Kang, Y-S Ha, Y S Jung, J Chung, K Min, T H Kim, K H Moon, J M Chung, D H Lee, W-J Kim & I Y Kim. (2014) Prostate cancer bone metastases acquire resistance to androgen deprivation via WNT5A-mediated BMP-6 induction. British Journal of Cancer 110:6, pages 1634-1644.
Crossref
Crossref
Eugine LeeAviv Madar, Gregory DavidMichael J. GarabedianRamanuj DasGupta & Susan K. Logan. (2013) Inhibition of androgen receptor and β-catenin activity in prostate cancer. Proceedings of the National Academy of Sciences 110:39, pages 15710-15715.
Crossref
Crossref
B Xu, L Gao, L Wang, G Tang, M He, Y Yu, X Ni & Y Sun. (2013) Effects of platelet-activating factor and its differential regulation by androgens and steroid hormones in prostate cancers. British Journal of Cancer 109:5, pages 1279-1286.
Crossref
Crossref
Xin-Hua Liu, Yong Wu, Shen Yao, Alice C. Levine, Alexander Kirschenbaum, Lauren Collier, William A. Bauman & Christopher P. Cardozo. (2013) Androgens Up-regulate Transcription of the Notch Inhibitor Numb in C2C12 Myoblasts via Wnt/β-Catenin Signaling to T Cell Factor Elements in the Numb Promoter. Journal of Biological Chemistry 288:25, pages 17990-17998.
Crossref
Crossref
Jeffrey C. Francis, Martin K. Thomsen, Makoto M. Taketo & Amanda Swain. (2013) β-Catenin Is Required for Prostate Development and Cooperates with Pten Loss to Drive Invasive Carcinoma. PLoS Genetics 9:1, pages e1003180.
Crossref
Crossref
Edward J. Kilbourne, Thomas Kenney, Susan Chippari, Christopher McNally, Yihe Wang, Ho-Sun Lam, Karthick Vishwanathan, Sunil Nagpal, Catherine C. Thompson & Eugene L. Piatnitski Chekler. (2013) Probing androgen receptor co-factor selectivity profiles: a chemical tool to determine cross-talk between androgen receptor and β-catenin in vivo. MedChemComm 4:3, pages 582.
Crossref
Crossref
Zijie Sun & Suk Hyung Lee. 2013. Androgen-Responsive Genes in Prostate Cancer. Androgen-Responsive Genes in Prostate Cancer
101
116
.
M. Grzesiak, K. Knapczyk-Stwora, M. Duda & M. Slomczynska. (2012) Elevated level of 17β-estradiol is associated with overexpression of FSHR, CYP19A1, and CTNNB1 genes in porcine ovarian follicles after prenatal and neonatal flutamide exposure. Theriogenology 78:9, pages 2050-2060.
Crossref
Crossref
Takakazu Mitani, Naoki Harada, Yoshihisa Nakano, Hiroshi Inui & Ryoichi Yamaji. (2012) Coordinated Action of Hypoxia-inducible Factor-1α and β-Catenin in Androgen Receptor Signaling. Journal of Biological Chemistry 287:40, pages 33594-33606.
Crossref
Crossref
Chen Pan, Ya-Peng Liu, Yan-Fang Li, Jin-Xia Hu, Jin-Peng Zhang, Hong-Mei Wang, Jing Li & Li-Chun Xu. (2012) Effects of cypermethrin on the ligand-independent interaction between androgen receptor and steroid receptor coactivator-1. Toxicology 299:2-3, pages 160-164.
Crossref
Crossref
Robert M. Kypta & Jonathan Waxman. (2012) Wnt/β-catenin signalling in prostate cancer. Nature Reviews Urology 9:8, pages 418-428.
Crossref
Crossref
Ravi Jasuja, Mikhail N. Zacharov & Shalender Bhasin. 2012. Testosterone. Testosterone
459
469
.
Olaf Hiort, Ralf Werner & Michael Zitzmann. 2012. Testosterone. Testosterone
33
59
.
Teodora Ribarska, Klaus-Marius Bastian, Annemarie Koch & Wolfgang A Schulz. (2012) Specific changes in the expression of imprinted genes in prostate cancer—implications for cancer progression and epigenetic regulation. Asian Journal of Andrology 14:3, pages 436-450.
Crossref
Crossref
Maria Sirakov, Seham Skah, Imtiaz Nisar Lone, Julien Nadjar, Dimitar Angelov & Michelina Plateroti. (2012) Multi-Level Interactions between the Nuclear Receptor TRα1 and the WNT Effectors β-Catenin/Tcf4 in the Intestinal Epithelium. PLoS ONE 7:4, pages e34162.
Crossref
Crossref
Hifzur Rahman Siddique, Shrawan Kumar Mishra, R. Jeffery Karnes & Mohammad Saleem. (2011) Lupeol, a Novel Androgen Receptor Inhibitor: Implications in Prostate Cancer Therapy. Clinical Cancer Research 17:16, pages 5379-5391.
Crossref
Crossref
Hai-bo SHENG, Bin XU, Jing-jing LIANG & Shan-rong LIU. (2010) Roles of androgen receptor and Wnt signaling pathway in prostate cancer. Academic Journal of Second Military Medical University 30:11, pages 1244-1246.
Crossref
Crossref
Marcy E. Beildeck, Edward P. Gelmann & Stephen, W. Byers. (2010) Cross-regulation of signaling pathways: An example of nuclear hormone receptors and the canonical Wnt pathway. Experimental Cell Research 316:11, pages 1763-1772.
Crossref
Crossref
Vanessa C. Thompson, Antonio Hurtado-Coll, Dmitry Turbin, Ladan Fazli, Melanie L. Lehman, Martin E. Gleave & Colleen C. Nelson. (2010) Relaxin drives Wnt signaling through upregulation of PCDHY in prostate cancer. The Prostate 70:10, pages 1134-1145.
Crossref
Crossref
Judy S. Crabtree, Edward J. Kilbourne, Bryan J. Peano, Susan Chippari, Thomas Kenney, Christopher McNally, Wei Wang, Heather A. Harris, Richard C. Winneker, Sunil Nagpal & Catherine C. Thompson. (2010) A Mouse Model of Androgenetic Alopecia. Endocrinology 151:5, pages 2373-2380.
Crossref
Crossref
Xunxian Liu, Julia T. Arnold & Marc R. Blackman. (2010) Dehydroepiandrosterone Administration or Gαq Overexpression Induces β-Catenin/T-Cell Factor Signaling and Growth via Increasing Association of Estrogen Receptor-β/Dishevelled2 in Androgen-Independent Prostate Cancer Cells. Endocrinology 151:4, pages 1428-1440.
Crossref
Crossref
James T. Dalton & Wenqing Gao. 2010. Nuclear Receptors. Nuclear Receptors
143
182
.
Edward P. Gelmann. 2010. Drug Management of Prostate Cancer. Drug Management of Prostate Cancer
61
70
.
Klaus-Dieter Spindler, C. Hönl, Ch. Tremmel, S. Braun, H. Ruff & M. Spindler-Barth. (2009) Ecdysteroid hormone action. Cellular and Molecular Life Sciences 66:24, pages 3837-3850.
Crossref
Crossref
Marcy E. Beildeck, Md Islam, Salimuddin Shah, JoEllen Welsh & Stephen W. Byers. (2009) Control of TCF-4 Expression by VDR and Vitamin D in the Mouse Mammary Gland and Colorectal Cancer Cell Lines. PLoS ONE 4:11, pages e7872.
Crossref
Crossref
Chen-Yin Ou, Jeong Hoon Kim, Catherine K. Yang & Michael R. Stallcup. (2009) Requirement of Cell Cycle and Apoptosis Regulator 1 for Target Gene Activation by Wnt and β-Catenin and for Anchorage-independent Growth of Human Colon Carcinoma Cells. Journal of Biological Chemistry 284:31, pages 20629-20637.
Crossref
Crossref
Gargi Bagchi, Christopher H. Hurst & David J. Waxman. (2009) Interactions of methoxyacetic acid with androgen receptor. Toxicology and Applied Pharmacology 238:2, pages 101-110.
Crossref
Crossref
Jennifer A. Hernandez Gifford, Mary E. Hunzicker-Dunn & John H. Nilson. (2009) Conditional Deletion of Beta-Catenin Mediated by Amhr2cre in Mice Causes Female Infertility1. Biology of Reproduction 80:6, pages 1282-1292.
Crossref
Crossref
Shalender Bhasin & Ravi Jasuja. (2009) Selective androgen receptor modulators as function promoting therapies. Current Opinion in Clinical Nutrition and Metabolic Care 12:3, pages 232-240.
Crossref
Crossref
Jean-Pierre Bergerat & Jocelyn Céraline. (2009) Pleiotropic functional properties of androgen receptor mutants in prostate cancer. Human Mutation 30:2, pages 145-157.
Crossref
Crossref
Wenyan Lu, Heather N. Tinsley, Adam Keeton, Zhican Qu, Gary A. Piazza & Yonghe Li. (2009) Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation. European Journal of Pharmacology 602:1, pages 8-14.
Crossref
Crossref
Matthew J. Tanner, Elina Levina, Michael Shtutman, Mengqian Chen, Patrice Ohouo & Ralph Buttyan. 2009. Androgen Action in Prostate Cancer. Androgen Action in Prostate Cancer
569
586
.
Alfonso Urbanucci, Kati K Waltering, Hanna E Suikki, Merja A Helenius & Tapio Visakorpi. (2008) Androgen regulation of the androgen receptor coregulators. BMC Cancer 8:1.
Crossref
Crossref
Liang Schweizer, Cheryl A Rizzo, Thomas E Spires, J Suso Platero, Qiuyan Wu, Tai-An Lin, Marco M Gottardis & Ricardo M Attar. (2008) The androgen receptor can signal through Wnt/β-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens. BMC Cell Biology 9:1.
Crossref
Crossref
Gang Wang, Jun Wang & Marianne D. Sadar. (2008) Crosstalk between the Androgen Receptor and β-Catenin in Castrate-Resistant Prostate Cancer. Cancer Research 68:23, pages 9918-9927.
Crossref
Crossref
Liang-Nian Song & Edward P. Gelmann. (2008) Silencing Mediator for Retinoid and Thyroid Hormone Receptor and Nuclear Receptor Corepressor Attenuate Transcriptional Activation by the β-Catenin-TCF4 Complex. Journal of Biological Chemistry 283:38, pages 25988-25999.
Crossref
Crossref
Morihisa Hirota, Kazuhide Watanabe, Shin Hamada, Youping Sun, Luigi Strizzi, Mario Mancino, Tadahiro Nagaoka, Monica Gonzales, Masaharu Seno, Caterina Bianco & David S. Salomon. (2008) Smad2 functions as a co-activator of canonical Wnt/β-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300. Cellular Signalling 20:9, pages 1632-1641.
Crossref
Crossref
Hayley C. Whitaker, Joanne Girling, Anne Y. Warren, Hing Leung, Ian G. Mills & David E. Neal. (2008) Alterations in β‐catenin expression and localization in prostate cancer. The Prostate 68:11, pages 1196-1205.
Crossref
Crossref
Xi Chen, Jun Yang, Paul M Evans & Chunming Liu. (2008) Wnt signaling: the good and the bad. Acta Biochimica et Biophysica Sinica 40:7, pages 577-594.
Crossref
Crossref
Jason Southwell, Shafinaz F. Chowdhury, Bruce Gottlieb, Lenore K. Beitel, Rose Lumbroso, Enrico O. Purisima & Mark Trifiro. (2008) An investigation into CAG repeat length variation and N/C terminal interactions in the T877A mutant androgen receptor found in prostate cancer. The Journal of Steroid Biochemistry and Molecular Biology 111:1-2, pages 138-146.
Crossref
Crossref
Travis B. Salisbury, April K. Binder & John H. Nilson. (2008) Welcoming β-Catenin to the Gonadotropin-Releasing Hormone Transcriptional Network in Gonadotropes. Molecular Endocrinology 22:6, pages 1295-1303.
Crossref
Crossref
Shlomo Handeli & Julian A. Simon. (2008) A small-molecule inhibitor of Tcf/β-catenin signaling down-regulates PPARγ and PPARδ activities. Molecular Cancer Therapeutics 7:3, pages 521-529.
Crossref
Crossref
P.-M. Martin, X. Muracciole, C. Berenguer, F. Boudouresque & L’H. Ouafik. (2008) Évolution de la cellule normale à la cellule cancéreuse prostatique hormonodépendante–hormono-indépendante. Médecine Nucléaire 32:1, pages 5-23.
Crossref
Crossref
Inken Wierstra & Jürgen Alves. 2008.
113
333
.
Edward P. Gelmann. 2008. Prostate Cancer. Prostate Cancer
71
97
.
Hannelore V. Heemers & Donald J. Tindall. (2007) Androgen Receptor (AR) Coregulators: A Diversity of Functions Converging on and Regulating the AR Transcriptional Complex. Endocrine Reviews 28:7, pages 778-808.
Crossref
Crossref
Jason T. Read, Maziar Rahmani, Seti Boroomand, Sima Allahverdian, Bruce M. McManus & Paul S. Rennie. (2007) Androgen Receptor Regulation of the Versican Gene through an Androgen Response Element in the Proximal Promoter. Journal of Biological Chemistry 282:44, pages 31954-31963.
Crossref
Crossref
Lisa G. Horvath, Jayne E. Lelliott, James G. Kench, C.-Soon Lee, Elizabeth D. Williams, Darren N. Saunders, John J. Grygiel, Robert L. Sutherland & Susan M. Henshall. (2007) Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. The Prostate 67:10, pages 1081-1090.
Crossref
Crossref
Luisella Cianferotti, Megan Cox, Kristi Skorija & Marie B. Demay. (2007) Vitamin D receptor is essential for normal keratinocyte stem cell function. Proceedings of the National Academy of Sciences 104:22, pages 9428-9433.
Crossref
Crossref
Sona Kang, Christina N. Bennett, Isabelle Gerin, Lauren A. Rapp, Kurt D. Hankenson & Ormond A. MacDougald. (2007) Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-binding Protein α and Peroxisome Proliferator-activated Receptor γ. Journal of Biological Chemistry 282:19, pages 14515-14524.
Crossref
Crossref
Travis B. Salisbury, April K. Binder, Jean C. Grammer & John H. Nilson. (2007) Maximal Activity of the Luteinizing Hormoneβ-Subunit Gene Requires β-Catenin. Molecular Endocrinology 21:4, pages 963-971.
Crossref
Crossref
Lotte N. Moens, Anneleen Soetaert, Karlijn van der Ven, Jurgen Del-Favero & Wim M. De Coen. (2007) Use of suppression subtractive hybridization PCR for the development of cDNA arrays for the detection of endocrine disruption in carp (Cyprinus carpio). Comparative Biochemistry and Physiology Part D: Genomics and Proteomics 2:1, pages 18-33.
Crossref
Crossref
Shin Hamada, Kazuhide Watanabe, Morihisa Hirota, Caterina Bianco, Luigi Strizzi, Mario Mancino, Monica Gonzales & David S. Salomon. (2007) β-Catenin/TCF/LEF regulate expression of the short form human Cripto-1. Biochemical and Biophysical Research Communications 355:1, pages 240-244.
Crossref
Crossref
David S. Parker, Timothy Blauwkamp & Ken M. Cadigan. 2007. Wnt Signaling in Embryonic Development. Wnt Signaling in Embryonic Development
1
60
.
Young-Ho Lee & Michael R. Stallcup. (2006) Interplay of Fli-I and FLAP1 for regulation of β-catenin dependent transcription. Nucleic Acids Research 34:18, pages 5052-5059.
Crossref
Crossref
Ulla Karvonen, Olli A. Jänne & Jorma J. Palvimo. (2006) Androgen receptor regulates nuclear trafficking and nuclear domain residency of corepressor HDAC7 in a ligand-dependent fashion. Experimental Cell Research 312:16, pages 3165-3183.
Crossref
Crossref
June X. Zou, Zhenyu Zhong, Xu-Bao Shi, Clifford G. Tepper, Ralph W. deVere White, Hsing-Jien Kung & Hongwu Chen. (2006) ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes. The Prostate 66:14, pages 1474-1486.
Crossref
Crossref
Stéphane Terry, Xuezhen Yang, Min-Wei Chen, Francis Vacherot & Ralph Buttyan. (2006) Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer. Journal of Cellular Biochemistry 99:2, pages 402-410.
Crossref
Crossref
X Yang, M-W Chen, S Terry, F Vacherot, D L Bemis, J Capodice, J Kitajewski, A de la Taille, M C Benson, Y Guo & R Buttyan. (2006) Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells. Oncogene 25:24, pages 3436-3444.
Crossref
Crossref
Sachiko Takayama, Inez Rogatsky, Leslie E. Schwarcz & Beatrice D. Darimont. (2006) The Glucocorticoid Receptor Represses Cyclin D1 by Targeting the Tcf-β-Catenin Complex. Journal of Biological Chemistry 281:26, pages 17856-17863.
Crossref
Crossref
Meletios Verras & Zijie Sun. (2006) Roles and regulation of Wnt signaling and β-catenin in prostate cancer. Cancer Letters 237:1, pages 22-32.
Crossref
Crossref
Randi L. Shand & Edward P. Gelmann. (2006) Molecular biology of prostate-cancer pathogenesis. Current Opinion in Urology 16:3, pages 123-131.
Crossref
Crossref
Salimuddin Shah, Md Naimul Islam, Sivanesan Dakshanamurthy, Imran Rizvi, Mahadev Rao, Roger Herrell, Glendon Zinser, Meggan Valrance, Ana Aranda, Dino Moras, Anthony Norman, JoEllen Welsh & Stephen W. Byers. (2006) The Molecular Basis of Vitamin D Receptor and β-Catenin Crossregulation. Molecular Cell 21:6, pages 799-809.
Crossref
Crossref
Catherine K. Yang, Jeong Hoon Kim, Hongwei Li & Michael R. Stallcup. (2006) Differential Use of Functional Domains by Coiled-coil Coactivator in Its Synergistic Coactivator Function with β-Catenin or GRIP1. Journal of Biological Chemistry 281:6, pages 3389-3397.
Crossref
Crossref
D J Mulholland, S Dedhar, H Wu & C C Nelson. (2006) PTEN and GSK3β: key regulators of progression to androgen-independent prostate cancer. Oncogene 25:3, pages 329-337.
Crossref
Crossref
Stephen Mbigha Ghogomu, Stephanie van Venrooy, Martin Ritthaler, Doris Wedlich & Dietmar Gradl. (2006) HIC-5 Is a Novel Repressor of Lymphoid Enhancer Factor/T-cell Factor-driven Transcription. Journal of Biological Chemistry 281:3, pages 1755-1764.
Crossref
Crossref
David J. Mulholland, Shoukat Dedhar, Gerhard A. Coetzee & Colleen C. Nelson. (2005) Interaction of Nuclear Receptors with the Wnt/β-Catenin/Tcf Signaling Axis: Wnt You Like to Know?. Endocrine Reviews 26:7, pages 898-915.
Crossref
Crossref
Kazunori Mizutani, Shizuyo Miyamoto, Takemitsu Nagahata, Noboru Konishi, Mitsuru Emi & Masamitsu Onda. (2019)
Upregulation and Overexpression of
DVL1
, the Human Counterpart of the
Drosophila
Dishevelled Gene, in Prostate Cancer
. Tumori Journal 91:6, pages 546-551.
Crossref
Crossref
Liang-Nian Song & Edward P. Gelmann. (2005) Interaction of β-Catenin and TIF2/GRIP1 in Transcriptional Activation by the Androgen Receptor. Journal of Biological Chemistry 280:45, pages 37853-37867.
Crossref
Crossref
Wenqing Gao, Casey E. Bohl & James T. Dalton. (2005) Chemistry and Structural Biology of Androgen Receptor. Chemical Reviews 105:9, pages 3352-3370.
Crossref
Crossref
Olivera Stojadinovic, Harold Brem, Constantinos Vouthounis, Brian Lee, John Fallon, Michael Stallcup, Ankit Merchant, Robert D. Galiano & Marjana Tomic-Canic. (2005) Molecular Pathogenesis of Chronic Wounds. The American Journal of Pathology 167:1, pages 59-69.
Crossref
Crossref
C Jung, R-S Kim, H Zhang, S-J Lee, H Sheng, P J Loehrer, T A Gardner, M-H Jeng & C Kao. (2005) HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation. British Journal of Cancer 92:12, pages 2233-2239.
Crossref
Crossref
Lisa G. Horvath, Susan M. Henshall, C.-Soon Lee, James G. Kench, David Golovsky, Phillip C. Brenner, Gordon F. O'Neill, Raji Kooner, Phillip D. Stricker, John J. Grygiel & Robert L. Sutherland. (2005) Lower levels of nuclear ?-catenin predict for a poorer prognosis in localized prostate cancer. International Journal of Cancer 113:3, pages 415-422.
Crossref
Crossref
Michael W. Klymkowsky. 2005. Rise and Fall of Epithelial Phenotype. Rise and Fall of Epithelial Phenotype
267
287
.
Chaeyong Jung, Ran-Sook Kim, Hong-Ji Zhang, Sang-Jin Lee & Meei-Huey Jeng. (2004) HOXB13 Induces Growth Suppression of Prostate Cancer Cells as a Repressor of Hormone-Activated Androgen Receptor Signaling. Cancer Research 64:24, pages 9185-9192.
Crossref
Crossref
Daqing Wu, Chittam U Thakore, Ginger G Wescott, James A McCubrey & David M Terrian. (2004) Integrin signaling links protein kinase Cɛ to the protein kinase B/Akt survival pathway in recurrent prostate cancer cells. Oncogene 23:53, pages 8659-8672.
Crossref
Crossref
David Masiello, Shao-Yong Chen, Youyuan Xu, Manon C. Verhoeven, Eunis Choi, Anthony N. Hollenberg & Steven P. Balk. (2004) Recruitment of β-Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells. Molecular Endocrinology 18:10, pages 2388-2401.
Crossref
Crossref
Jiajian Liu & Stephen R. Farmer. (2004) Regulating the Balance between Peroxisome Proliferator-activated Receptor γ and β-Catenin Signaling during Adipogenesis. Journal of Biological Chemistry 279:43, pages 45020-45027.
Crossref
Crossref
Qingjie Li & Roderick H. Dashwood. (2004) Activator Protein 2α Associates with Adenomatous Polyposis Coli/β-Catenin and Inhibits β-Catenin/T-cell Factor Transcriptional Activity in Colorectal Cancer Cells. Journal of Biological Chemistry 279:44, pages 45669-45675.
Crossref
Crossref
Chandan Sharma, Anamika Pradeep, Lucas Wong, Ajay Rana & Basabi Rana. (2004) Peroxisome Proliferator-activated Receptor γ Activation Can Regulate β-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway. Journal of Biological Chemistry 279:34, pages 35583-35594.
Crossref
Crossref
Jennifer R Wood, Clement K.M Ho, Velen L Nelson-Degrave, Jan M McAllister & Jerome F StraussIIIIII. (2004) The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling. Journal of Reproductive Immunology 63:1, pages 51-60.
Crossref
Crossref
Tarek A. Bismar, Peter A. Humphrey, David J. Grignon & Hanlin L. Wang. (2004) Expression of β-Catenin in Prostatic Adenocarcinomas. American Journal of Clinical Pathology 121:4, pages 557-563.
Crossref
Crossref
Dennis R. Chesire, Thomas A. Dunn, Charles M. Ewing, Jun Luo & William B. Isaacs. (2004) Identification of Aryl Hydrocarbon Receptor as a Putative Wnt/β-Catenin Pathway Target Gene in Prostate Cancer Cells. Cancer Research 64:7, pages 2523-2533.
Crossref
Crossref
Hongwei Li, Jeong Hoon Kim, Stephen S. Koh & Michael R. Stallcup. (2004) Synergistic Effects of Coactivators GRIP1 and β-Catenin on Gene Activation. Journal of Biological Chemistry 279:6, pages 4212-4220.
Crossref
Crossref
Hellmuth-Alexander Meyer, Isabelle Ahrens-Fath, Anette Sommer & Bernard Haendler. (2004) Novel molecular aspects of prostate carcinogenesis. Biomedicine & Pharmacotherapy 58:1, pages 10-16.
Crossref
Crossref
Salimuddin Shah, Andreas Hecht, Richard Pestell & Stephen W. Byers. (2003) Trans-repression of β-Catenin Activity by Nuclear Receptors. Journal of Biological Chemistry 278:48, pages 48137-48145.
Crossref
Crossref
Brian K. Jordan, Jennifer H.-C. Shen, Robert Olaso, Holly A. Ingraham & Eric Vilain. (2003) Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/β-catenin synergy. Proceedings of the National Academy of Sciences 100:19, pages 10866-10871.
Crossref
Crossref
Hiroko Natsume, Shigekazu Sasaki, Masatoshi Kitagawa, Yumiko Kashiwabara, Akio Matsushita, Keiko Nakano, Kozo Nishiyama, Koji Nagayama, Hiroko Misawa, Hiroko Masuda & Hirotoshi Nakamura. (2003) β-Catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone. Biochemical and Biophysical Research Communications 309:2, pages 408-413.
Crossref
Crossref
David J Mulholland, Jason T Read, Paul S Rennie, Michael E Cox & Colleen C Nelson. (2003) Functional localization and competition between the androgen receptor and T-cell factor for nuclear β-catenin: a means for inhibition of the Tcf signaling axis. Oncogene 22:36, pages 5602-5613.
Crossref
Crossref
Avital L. Amir, Moumita Barua, Nicole C. McKnight, Shinta Cheng, Xin Yuan & Steven P. Balk. (2003) A Direct β-Catenin-independent Interaction between Androgen Receptor and T Cell Factor 4. Journal of Biological Chemistry 278:33, pages 30828-30834.
Crossref
Crossref